Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review, review of facility policy, and review of McGeer's criteria, revealed the facility failed to follow antibiotic stewardship for two residents (#10 and #15) of seven residents reviewed for infection control. The facility census was 70.Findings include:1. Review of Resident #15's medical record revealed an admission date of 07/17/24 with diagnoses including acute respiratory failure with hypoxia, type two diabetes mellitus, major depressive disorder, unspecified dementia, and cognitive communication deficit.Review of Resident #15's comprehensive Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed severely impaired cognition.Review of Resident #15's progress note dated 01/09/26 revealed the nurse assessed a skin issue to the residents' right inner thigh. The area was hard to the touch, large in measurement, and raised with no discoloration. Resident #15 only reported pain in the area when it was touched. An additional progress note on 01/09/26 revealed the Certified Nurse Practitioner (CNP) gave a new order to start Cephalexin 500 milligrams (mg) one capsule twice a day for seven days for cellulitis.Review of Resident #15's infection tracker dated 01/09/26 revealed most questions were left unanswered including the type of infection, if the surveillance definition was met, if it was a reportable infection, her history, symptoms, onset date, and diagnostic testing. The only areas completed were responsible party notifications, new orders, and attached progress notes. The evaluation notes stated the resident remained with a lump however the antibiotic was completed and a Doppler and ultrasound were completed and negative for a deep vein thrombosis. The final question on the form was if the symptoms resolved and treatment was completed, to which there was a check mark and the answer, no.Review of Resident #15's physician orders dated 01/09/26 to 01/16/26 revealed an order for Cephalexin 500 mg one capsule twice a day. To start with bedtime dose on 01/09/26 and end upon rising on 01/16/26.Interview on 02/12/26 at 9:23 A.M. with MDS Nurse #120 revealed the facility was supposed to follow McGeer's criteria for infections. She verified Resident #15 did not meet McGeer's criteria for antibiotics and that there was no evidence the physician was notified of this. Review of the McGeer's criteria checklist for cellulitis, soft tissue or wound infections, dated 11/05/24, revealed at least one criterion must be met: either pus at the wound, skin, or soft tissue site; at least four of the following new or increasing signs or symptoms, heat (warmth) at affected site, redness (erythema) at affected site, swelling at affected site, tenderness or pain at affected site, serous drainage at the affected site; or at least one of the following: fever, leukocytosis, acute changed in mental status, or acute functional decline. 2. Review of Resident #10's medical record revealed an admission date of 09/25/19 with diagnoses including type two diabetes mellitus, major depressive disorder, hemiplegia and hemiparesis affecting left non-dominant side, and osteoarthritis.Review of Resident #10's quarterly Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed she had intact cognition.Review of Resident #10's progress note dated 02/06/26 revealed the resident had an open area from Moisture Associated Skin Damage (MASD) on her right buttock. The nurse also noted the resident's right index finger was reddened around the cuticle and slightly swollen at the end of the fingernail. Hospice was made aware and gave orders for Clindamycin.Review of Resident #10's infection tracker dated 02/06/26 revealed the resident had a soft tissue infection of the right buttock and suspected cellulitis of the right index finger. Symptoms included her right buttock was extremely red and excoriated and her right index finger was red and slightly swollen. No other symptoms were indicated and no other diagnostics were performed.Review of Resident #10's physician order dated 02/07/26 to 02/16/26 revealed an order for Clindamycin 300 milligrams (mg) three times a day.Interview on 02/12/26 at 9:23 A.M. with MDS Nurse #120 revealed the facility was supposed to follow McGeer's criteria for infections. She verified Resident #10 did not meet McGeer's criteria for antibiotics and that there was no evidence the physician was notified of this. Review of the McGeer's criteria checklist for cellulitis, soft tissue or wound infections, dated 11/05/24, revealed at least one criterion must be met: either pus at the wound, skin, or soft tissue site; at least four of the following new or increasing signs or symptoms, heat (warmth) at affected site, redness (erythema) at affected site, swelling at affected site, tenderness or pain at affected site, serous drainage at the affected site; or at least one of the following: fever, leukocytosis, acute changed in mental status, or acute functional decline. Review of the policy 'Antibiotic Stewardship/infection Control' revealed it was facility policy to implement an antibiotic stewardship program that promoted appropriate use of antibiotics while optimizing treatment of infections and reducing the possible adverse events associated with antibiotics.